Mattson Technology, Inc. is a leading supplier of dry strip equipment and the second largest supplier of rapid thermal processing equipment in the global semiconductor industry. The company's strip and RTP equipment utilize innovative technology to deliver advanced processing performance and productivity gains to semiconductor manufacturers worldwide for the fabrication of current- and next-generation devices.
The company manufactures precision optical calibration targets; is a photolithography production house; and also does thin film PVD coating. In their engineering division they also do diamond turning, thick film ceramic patterning, conformal patterning/coatings, and large format roll to roll processing.
MSI's technology for multi-step multi-analyte chemiluminescent assays combines microfluidics, nanotechnology, and optoelectronics designed for both Immunoassay and Nucleic Acid Hybridization based applications.
The MayaTech Corporation, a provider of consulting and technical services to Federal agencies, has expanded its services with the establishment of the Center for NanoSystems Technology Applications (NSTA). The center will study the legal, regulatory, ethical, and social implications of nanotechnology and its applications.
The company is focused on realizing the potential of RNAi-based therapeutics through the development of a broad-based, state-of-the-art drug discovery platform built upon industry leading expertise in RNA chemistry and oligonucleotide delivery.
Meaglow Ltd. manufactures and sells crystal growth reactors and supplies thin films to semiconductor research institutes and industry. The company specializes in producing Indium Nitride (InN) thin films via its CVD based migration enhanced afterglow deposition process.
MEARS Technologies develops advanced CMOS solutions and associated manufacturing technology for leading-edge semiconductor chip producers and contract foundries to achieve competitive advantages at sub-micron levels.
Meda Biotech is a clinical-stage biopharmaceutical company developing a new class of Hybrid- Nanoengineering™ platform enables the design, engineering and manufacturing of Hybrid water soluble drugs with unprecedented control over drug properties to maximize trafficking to disease sites, dramatically enhancing efficacy while minimizing toxicities.
The company is a leading international provider of complete innovative polymer engineering solutions. MERL provides complete testing solutions from concept/feasibility and materials selection to disposal and re-use